Psoriasis | AbbVie | M15-997
Pharmaceutical Company/Sponsor:
AbbVie
Code:
M15-997
Title:
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Type:
Interventional
Phase:
3
Condition/Disease:
Psoriasis
Intervention(s)/Treatment(s):
Biological: Risankizumab
Status:
Active, Not Recruiting
Link for Additional Information:
